Insider 10b5-1 sales and RSU/PSU listings at ISRG (ISRG)
Rhea-AI Filing Summary
Mark Brosius reported insider sales under 10b5-1 plans and listed planned dispositions of equity awards. The excerpt shows three 10b5-1 sales in December 2025: 4,500, 464, and 312 shares, with proceeds of $2,463,120.00, $254,499.36, and $170,776.32 respectively. It also lists 2,154 Restricted Stock Units dated 02/10/2026 and 1,173 Performance Stock Units dated 02/28/2026 as securities to be sold.
Positive
- None.
Negative
- None.
Insights
Filed 10b5-1 sales by an individual with recent December 2025 transactions and upcoming RSU/PSU dispositions.
Records show three executed 10b5-1 sales in December 2025 totaling 5,276 shares sold for aggregate proceeds shown across the three trades. The filing lists planned sales of 2,154 Restricted Stock Units and 1,173 Performance Stock Units with grant dates in February 2026.
Timing and cash‑flow treatment are governed by the 10b5‑1 instruction and award terms; the excerpt does not state who will receive proceeds from the RSU/PSU dispositions. Subsequent filings would clarify settlement mechanics and any remaining holder limits.